CECONOMY AG
CECONOMY AG: FY 2021/22 – Sales above previous year, adjusted EBIT in the upper range of the guidance (news with additional features)

FY 2021/22: Sales above previous year, adjusted EBIT in the upper range of the Guidance

Düsseldorf, 26 October 2022

• Total sales in FY 2021/22 grew by +3.2%¹ on previous year to €21.8 bn and exceed FY guidance; robust development well supported by strong growth in Services & Solutions business.
• Q4 2021/22 sales rose by +3.6%¹ vs. previous year – strong increase of online sales.
• Adjusted EBIT² in FY 2021/22 of around €200 m in the upper range of the guidance; adjusted EBIT in Western/Southern Europe and Eastern Europe above previous year.

”Our robust development at the end of financial year 2021/22 shows that our measures are taking effect. Despite the challenging market environment, we managed to grow sales compared to the previous year and achieved a result in the upper range of our current EBIT guidance. We are continuing to optimize our cost structures and focusing on improving profitability. Moreover, we will further strengthen our liquidity.

Our customers are our top priority. We are directing all our efforts towards further enhancing the shopping experience and customer satisfaction across all channels. We grew our Services & Solutions business by more than 20% year-on-year and almost doubled the inhouse share of our online business compared to pre-COVID levels.  

With our Europe-wide ´Let’s Go´ campaign, we are achieving high reach in 13 countries and look forward to delighting our customers with attractive product offerings and outstanding services, especially in the peak season around Black Friday and Christmas.“

Dr Karsten Wildberger, CEO CECONOMY AG.

All figures published herein are preliminary and unaudited. Full financial disclosure of the results for the 2021/22 financial year will be published on 15 December 2022 at 07:00 CET.

¹Total sales growth = Sales growth adjusted for currency effects, IAS 29 and portfolio changes
²Adjusted EBIT = EBIT before non-recurring effects, associates and portfolio changes